Search Results
Search for other papers by Nikolaj Rittig in
Google Scholar
PubMed
Search for other papers by Mads Svart in
Google Scholar
PubMed
Search for other papers by Niels Jessen in
Google Scholar
PubMed
Search for other papers by Niels Møller in
Google Scholar
PubMed
Search for other papers by Holger J Møller in
Google Scholar
PubMed
Search for other papers by Henning Grønbæk in
Google Scholar
PubMed
as obesity, sepsis, insulin resistance, diabetes mellitus type 2 (DM2) and non-alcoholic fatty liver disease (NAFLD) ( 1 , 2 , 3 , 4 , 5 , 6 ). These diseases are also associated with changes in the lipid metabolism, accelerated lipolysis and
Aix Marseille University, INSERM, INRA, C2VN, Marseille, France
Search for other papers by Sandrine Visentin in
Google Scholar
PubMed
Research Unit EA 3279 and Department of Public Health, Aix-Marseille University, Marseille, France
Search for other papers by Gérard Michel in
Google Scholar
PubMed
Research Unit EA 3279 and Department of Public Health, Aix-Marseille University, Marseille, France
Search for other papers by Claire Oudin in
Google Scholar
PubMed
Search for other papers by Béatrice Cousin in
Google Scholar
PubMed
Search for other papers by Bénédicte Gaborit in
Google Scholar
PubMed
Search for other papers by Inès Abdesselam in
Google Scholar
PubMed
Search for other papers by Marie Maraninchi in
Google Scholar
PubMed
Search for other papers by Marion Nowicki in
Google Scholar
PubMed
Nutrition, Metabolic Diseases and Endocrinology Department, AP-HM, La Conception Hospital, Marseille, France
Search for other papers by René Valéro in
Google Scholar
PubMed
Search for other papers by Maxime Guye in
Google Scholar
PubMed
Aix-Marseille University, CNRS, CRMBM, Marseille, France
Search for other papers by Monique Bernard in
Google Scholar
PubMed
Search for other papers by Pascal Auquier in
Google Scholar
PubMed
Search for other papers by Hervé Chambost in
Google Scholar
PubMed
Search for other papers by Marie-Christine Alessi in
Google Scholar
PubMed
Nutrition, Metabolic Diseases and Endocrinology Department, AP-HM, La Conception Hospital, Marseille, France
Search for other papers by Sophie Béliard in
Google Scholar
PubMed
be protective against NAFLD (nonalcoholic fatty liver disease) ( 35 ). Similarly, we observed a significantly higher rate of liver steatosis associated with a lower BMI, and a trend toward decreased TAT and SAT after TBI in patients who had been
Search for other papers by Karim Gariani in
Google Scholar
PubMed
Service of Endocrinology, Laboratory of Intensive Care, Department of Microbiology and Molecular Medicine, Diabetes, Hypertension and Nutrition
Search for other papers by Geneviève Drifte in
Google Scholar
PubMed
Service of Endocrinology, Laboratory of Intensive Care, Department of Microbiology and Molecular Medicine, Diabetes, Hypertension and Nutrition
Search for other papers by Irène Dunn-Siegrist in
Google Scholar
PubMed
Service of Endocrinology, Laboratory of Intensive Care, Department of Microbiology and Molecular Medicine, Diabetes, Hypertension and Nutrition
Search for other papers by Jérôme Pugin in
Google Scholar
PubMed
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
lipid alterations, and FGF21 is considered as a key regulator in glucose and lipid metabolism (1, 6, 7, 8, 11) . FGF21 plasma levels are increased in type 2 diabetes, obesity, nonalcoholic fatty liver disease (NAFLD) and dyslipidemia (35, 36, 37, 38
Search for other papers by Min Li in
Google Scholar
PubMed
Search for other papers by Ying Chen in
Google Scholar
PubMed
Search for other papers by Jingjing Jiang in
Google Scholar
PubMed
Search for other papers by Yan Lu in
Google Scholar
PubMed
Search for other papers by Zhiyi Song in
Google Scholar
PubMed
Search for other papers by Shengjie Zhang in
Google Scholar
PubMed
Search for other papers by Chao Sun in
Google Scholar
PubMed
Search for other papers by Hao Ying in
Google Scholar
PubMed
Search for other papers by Xiaofang Fan in
Google Scholar
PubMed
Search for other papers by Yuping Song in
Google Scholar
PubMed
Search for other papers by Jialin Yang in
Google Scholar
PubMed
Search for other papers by Lin Zhao in
Google Scholar
PubMed
production through the regulation of phosphoenolpyruvate carboxykinase (PEPCK) ( 32 , 33 ). In addition, recent studies have demonstrated that impaired thyroid action is associated with nonalcoholic fatty liver disease (NAFLD), and selective TH receptor
Search for other papers by Lei Gao in
Google Scholar
PubMed
Search for other papers by Wenxia Cui in
Google Scholar
PubMed
Search for other papers by Dinghuang Mu in
Google Scholar
PubMed
Search for other papers by Shaoping Li in
Google Scholar
PubMed
Search for other papers by Nan Li in
Google Scholar
PubMed
Search for other papers by Weihong Zhou in
Google Scholar
PubMed
Search for other papers by Yun Hu in
Google Scholar
PubMed
Introduction In 2023, international authorities adopted the nomenclature metabolic dysfunction-associated steatotic liver disease (MASLD), which was originally referred to as non-alcoholic fatty liver disease (NAFLD) ( 1 ). The estimated
Xiamen Diabetes Institute, The First Affiliated Hospital of Xiamen University, Xiamen, China
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Search for other papers by Weiwei He in
Google Scholar
PubMed
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Search for other papers by Caoxin Huang in
Google Scholar
PubMed
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Department of Endocrinology and Diabetes, The First Affiliated Hospital of Xiamen University, Xiamen, China
Search for other papers by Xiulin Shi in
Google Scholar
PubMed
Xiamen Diabetes Institute, The First Affiliated Hospital of Xiamen University, Xiamen, China
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Search for other papers by Menghua Wu in
Google Scholar
PubMed
Xiamen Diabetes Institute, The First Affiliated Hospital of Xiamen University, Xiamen, China
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Search for other papers by Han Li in
Google Scholar
PubMed
Xiamen Diabetes Institute, The First Affiliated Hospital of Xiamen University, Xiamen, China
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Search for other papers by Qiuhong Liu in
Google Scholar
PubMed
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Search for other papers by Xiaofang Zhang in
Google Scholar
PubMed
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Search for other papers by Yan Zhao in
Google Scholar
PubMed
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Department of Endocrinology and Diabetes, The First Affiliated Hospital of Xiamen University, Xiamen, China
Xiamen Clinical Medical Center for Endocrine and Metabolic Diseases, Xiamen Diabetes Prevention and Treatment Center, Xiamen, China
Search for other papers by Xuejun Li in
Google Scholar
PubMed
Introduction Non-alcoholic fatty liver disease (NAFLD), as the main liver disease manifestation of metabolic diseases, is closely related to obesity, insulin resistance, type 2 diabetes, and dyslipidemia ( 1 , 2 ). With the improvement of
Search for other papers by Silan Zheng in
Google Scholar
PubMed
Search for other papers by Meifeng Tong in
Google Scholar
PubMed
Search for other papers by Lianqin Dong in
Google Scholar
PubMed
Search for other papers by Chunmin Du in
Google Scholar
PubMed
Search for other papers by Xin Zheng in
Google Scholar
PubMed
Search for other papers by Liying Wang in
Google Scholar
PubMed
Search for other papers by Peiying Huang in
Google Scholar
PubMed
Search for other papers by Wei Liu in
Google Scholar
PubMed
Search for other papers by Mingzhu Lin in
Google Scholar
PubMed
The School of Clinical Medicine, Fujian Medical University, Fuzhou, China
Search for other papers by Changqin Liu in
Google Scholar
PubMed
nonalcoholic fatty liver disease (NAFLD) ( 2 ). A growing body of clinical and experimental evidences suggest that PCOS and NAFLD share similar clinical presentations including dyslipidemia, hypertension, and glycemic dysregulation ( 3 ). NAFLD is one of the
Search for other papers by Lena-Maria Levin in
Google Scholar
PubMed
DZHK (German Centre for Cardiovascular Research), Greifswald, Germany
DZD (German Center for Diabetes Research), Greifswald, Germany
Search for other papers by Henry Völzke in
Google Scholar
PubMed
Search for other papers by Markus M Lerch in
Google Scholar
PubMed
Institute and Policlinic for Radiology and Interventional Radiology, University Hospital, Carl-Gustav-Carus University Dresden, Dresden, Germany
Search for other papers by Jens-Peter Kühn in
Google Scholar
PubMed
DZHK (German Centre for Cardiovascular Research), Greifswald, Germany
Search for other papers by Matthias Nauck in
Google Scholar
PubMed
DZHK (German Centre for Cardiovascular Research), Greifswald, Germany
Search for other papers by Nele Friedrich in
Google Scholar
PubMed
DZHK (German Centre for Cardiovascular Research), Greifswald, Germany
Search for other papers by Stephanie Zylla in
Google Scholar
PubMed
, 5 ). Because adipokines affect insulin sensitivity in the liver ( 4 ) and their circulating concentrations are altered in patients with nonalcoholic fatty liver disease (NAFLD) ( 3 , 4 ), they have been considered to play a role in the pathogenesis
Search for other papers by Agnieszka Adamska in
Google Scholar
PubMed
Search for other papers by Aleksandra Maria Polak in
Google Scholar
PubMed
Search for other papers by Anna Krentowska in
Google Scholar
PubMed
Search for other papers by Agnieszka Łebkowska in
Google Scholar
PubMed
Search for other papers by Justyna Hryniewicka in
Google Scholar
PubMed
Search for other papers by Monika Leśniewska in
Google Scholar
PubMed
Search for other papers by Irina Kowalska in
Google Scholar
PubMed
disease ( 3 ) and non-alcoholic fatty liver disease (NAFLD) ( 1 ). NAFLD is histologically defined by the presence of steatosis in at least 5% of liver tissue and is the most common reason of chronic liver disease in many parts of the world ( 4 ). The
Faculty of Medicine, School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan
Department of Family Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
Search for other papers by Hsiao-Yun Yeh in
Google Scholar
PubMed
Division of Musculoskeletal Section, Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan
Search for other papers by Hung-Ta Hondar Wu in
Google Scholar
PubMed
Faculty of Medicine, School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan
Search for other papers by Hsiao-Chin Shen in
Google Scholar
PubMed
School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei, Taiwan
Search for other papers by Tzu-Hao Li in
Google Scholar
PubMed
Faculty of Medicine, School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
Search for other papers by Ying-Ying Yang in
Google Scholar
PubMed
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
Search for other papers by Kuei-Chuan Lee in
Google Scholar
PubMed
Faculty of Medicine, School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan
Department of Family Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
Search for other papers by Yi-Hsuan Lin in
Google Scholar
PubMed
Faculty of Medicine, School of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan
Search for other papers by Chia-Chang Huang in
Google Scholar
PubMed
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
Search for other papers by Ming-Chih Hou in
Google Scholar
PubMed
. Nonalcoholic fatty liver disease is associated with decreased bone mineral density in adults: a systematic review and meta-analysis . Journal of Bone and Mineral Research 2023 38 1092 – 1103 . ( https://doi.org/10.1002/jbmr.4862 ) 4 Targher G Lonardo A